Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $456.84 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $134.26 | 4 | $0 (2022) |
| PFIZER INC. | $89.15 | 2 | $0 (2023) |
| Inspire Medical Systems, Inc. | $76.53 | 1 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $59.55 | 3 | $0 (2021) |
| Boston Scientific Corporation | $46.90 | 1 | $0 (2022) |
| HEARTFLOW, INC. | $31.92 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $18.53 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108.45 | 2 | Inspire Medical Systems, Inc. ($76.53) |
| 2023 | $67.30 | 1 | PFIZER INC. ($67.30) |
| 2022 | $88.64 | 3 | Boston Scientific Corporation ($46.90) |
| 2021 | $192.45 | 7 | Novartis Pharmaceuticals Corporation ($92.52) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $76.53 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $31.92 | General |
| Category: Coronary | ||||||
| 09/21/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $67.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $46.90 | General |
| Category: WATCHMAN_IC | ||||||
| 11/09/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Genetic Disease | ||||||
| 07/01/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Genetic Disease | ||||||
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2021 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Genetic Disease | ||||||
| 04/01/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,938 | 2,275 | $814,134 | $74,518 |
| 2022 | 18 | 3,832 | 4,948 | $1.9M | $192,311 |
| 2021 | 3 | 161 | 195 | $101,509 | $19,284 |
| 2020 | 4 | 190 | 210 | $96,617 | $15,962 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 221 | $107,419 | $18,616 | 17.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 238 | 321 | $75,114 | $7,824 | 10.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 435 | 503 | $165,990 | $6,934 | 4.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 312 | 371 | $123,543 | $6,883 | 5.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 119 | 124 | $63,233 | $6,467 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 62 | $18,676 | $3,548 | 19.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 147 | 198 | $43,362 | $3,380 | 7.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 124 | 133 | $72,086 | $3,154 | 4.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $11,091 | $2,611 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $10,744 | $2,559 | 23.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 35 | 39 | $32,787 | $2,463 | 7.5% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 35 | 37 | $22,654 | $2,146 | 9.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 91 | 123 | $32,472 | $2,117 | 6.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 31 | $7,037 | $1,675 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,748 | $1,275 | 22.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,476 | $1,066 | 23.8% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 15 | 15 | $10,265 | $902.53 | 8.8% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 16 | 17 | $6,681 | $717.12 | 10.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $756.00 | $178.74 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 338 | 387 | $225,788 | $41,076 | 18.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 785 | 991 | $326,995 | $25,609 | 7.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 337 | 398 | $199,347 | $24,976 | 12.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2022 | 1,005 | 1,249 | $408,506 | $24,673 | 6.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 319 | 542 | $121,248 | $16,602 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 129 | $51,058 | $8,861 | 17.4% |
About Matthew Shryock, FNP
Matthew Shryock, FNP is a Nurse Practitioner healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1043862774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Matthew Shryock, FNP has received a total of $456.84 in payments from pharmaceutical and medical device companies, with $108.45 received in 2024. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($456.84).
As a Medicare-enrolled provider, Shryock has provided services to 6,121 Medicare beneficiaries, totaling 7,628 services with total Medicare billing of $302,075. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Acute Care
- Location Missoula, MT
- Active Since 07/12/2019
- Last Updated 08/22/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1043862774
Products in Payments
- ENTRESTO (Drug) $134.26
- INSPIRE (Device) $76.53
- VYNDAQEL (Drug) $67.30
- ONPATTRO (Drug) $59.55
- WATCHMAN Access System (Device) $46.90
- FFRct (Device) $31.92
- ELIQUIS (Drug) $21.85
- BRILINTA (Drug) $18.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Missoula
Sarah Berg
Nurse Practitioner — Payments: $254,634
Mallory Buck, Aprn, APRN
Nurse Practitioner — Payments: $4,366
Mr. Benjamin Miller, Arnp, ARNP
Nurse Practitioner — Payments: $823.16
Charlene De Grassi, Fnp-C, FNP-C
Nurse Practitioner — Payments: $629.57
Dr. Kirsten Marion, Dnp, Aprn, DNP, APRN
Nurse Practitioner — Payments: $524.44
Mrs. Taylor Stille, Arnp, ARNP
Nurse Practitioner — Payments: $505.04